Zoar Ltd ZOAR
Trading Information
- Previous Close Price
- $4.36
- Day Range
- $3.32–4.01
- 52-Week Range
- $3.32–6.55
- Bid/Ask
- $2.45 / $5.14
- Shares Outstanding
- 180.00M
- Market Cap
- $608.40M
- Volume/Avg
- 21,830 / 36,639
Key Statistics
- Price/Earnings (Normalized)
- 10.10
- Price/Sales
- 1.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zoar Ltd is a pharmaceutical company that specializes in the development, manufacturing and distribution of APIs and intermediates. It provides contract development and manufacturing organization (CDMO) services for complex APIs and intermediates used in specialized therapeutic areas. Its services include chemical composition analysis, formulation development, API and intermediate manufacturing, and quality control. The company works with contract manufacturing organizations (CMOs) for manufacturing activities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.zoarlimited.com
Valuation
Metric | ZOAR |
|---|---|
Price/Earnings (Normalized) | 10.10 |
Price/Book Value | — |
Price/Sales | 1.20 |
Price/Cash Flow | 9.67 |
Price/Earnings
ZOAR
Financial Strength
Metric | ZOAR |
|---|---|
Quick Ratio | 1.53 |
Current Ratio | 3.37 |
Interest Coverage | 136.68 |
Quick Ratio
ZOAR
Profitability
Metric | ZOAR |
|---|---|
Return on Assets (Normalized) | 13.57% |
Return on Equity (Normalized) | 20.67% |
Return on Invested Capital (Normalized) | 20.24% |
Return on Assets
ZOAR
Drug Manufacturers - General Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Eli Lilly and Co LLY | LOCK|G&dF<&# | LOCK|%zD | $1T | |||
| Johnson & Johnson JNJ | LOCK|sr!$^t | LOCK|BG | $643B | |||
| AbbVie Inc ABBV | LOCK|@XV$XxY | LOCK|$@ | $501B | |||
| Roche Holding AG ADR RHHBY | LOCK|JnpvMDZd | LOCK|NcF | $378B | |||
| Merck & Co Inc MRK | LOCK|d^xznB | LOCK|Xs^ | $327B | |||
| Novartis AG ADR NVS | LOCK|&P$P<ZTb | LOCK|&& | $285B | |||
| AstraZeneca PLC AZN | LOCK|>s^x$CWc | LOCK|>l> | $271B | |||
| Amgen Inc AMGN | LOCK|>@$!?t^ | LOCK|y& | $237B | |||
| Gilead Sciences Inc GILD | LOCK|KJp%j!C | LOCK|b># | $207B | |||
| Novo Nordisk AS ADR NVO | LOCK|$JV^tDs | LOCK|<&% | $172B |